Neurocrine Bio. (NBIX) PT Trimmed at Jeffereis, 'Buy' Maintained

May 1, 2014 8:03 AM

Jefferies analyst Thomas Wei trimmed his price target on Neurocrine Bio. (NASDAQ: NBIX) to $21.00 (from $23.00) but maintained a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found